Straits Times Index
3,110.73 +36.47 (+1.19%) S&P 500
4,604.37 +18.78 (+0.41%) Dow
36,247.87 +130.47 (+0.36%) Nasdaq
14,403.97 +63.97 (+0.45%) Bitcoin USD
43,708.49 +8.23 (+0.02%) CMC Crypto 200
914.81 +18.10 (+2.02%)
Tandem Diabetes Care, Inc. (0M0F.L)
| Previous close | 23.24 |
| Open | 23.88 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 23.77 - 24.67 |
| 52-week range | 13.89 - 44.34 |
| Volume | |
| Avg. volume | 552 |
| Market cap | 13.779M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 2.73 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
SAN DIEGO, December 06, 2023--Tandem Diabetes Care today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 CGM integration in the United States.
- Business Wire
Tandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO, November 06, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
- Business Wire
Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
SAN DIEGO, November 01, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for nearly 25 years.
